Medicine and Dentistry
Radiation Therapy
100%
Head and Neck Cancer
68%
Neck
62%
Oropharynx Carcinoma
46%
Intensity Modulated Radiation Therapy
42%
Disease
35%
Overall Survival
29%
Neoplasm
28%
Malignant Neoplasm
25%
Recurrent Disease
22%
Proton Therapy
21%
Wart Virus
16%
Chemotherapy
15%
Squamous Cell Carcinoma
14%
Chemoradiotherapy
14%
Head and Neck Squamous Cell Carcinoma
12%
Plummer-Vinson Syndrome
12%
Survival Rate
11%
Magnetic Resonance Imaging
11%
Xerostomia
11%
Re-Irradiation
10%
Oncology
9%
P16
9%
Oropharynx
9%
Cisplatin
9%
Carcinoma
9%
Patient-Reported Outcome
8%
Progression Free Survival
8%
Larynx
7%
Nasopharynx Carcinoma
7%
Distant Metastasis
7%
Oropharynx Squamous Cell Carcinoma
7%
Paclitaxel
7%
Primary Tumor
6%
Hazard Ratio
6%
Quality of Life
6%
Neck Dissection
6%
Cancer Therapy
6%
Cancer
6%
Phase II Trials
6%
Skin Carcinoma
6%
Surgery
6%
Clinical Trial
5%
Laryngeal Cancer
5%
Tonsil Cancer
5%
Tongue
5%
Induction Chemotherapy
5%
Neck Radiotherapy
5%
Cetuximab
5%
Mucositis
5%
Keyphrases
Head-and-neck Cancer
40%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
35%
Head-and-neck
34%
Radiation Therapy
28%
Radiotherapy
21%
Overall Survival
19%
Intensity-modulated Radiation Therapy
16%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
14%
Cancer Patients
12%
High-risk Human Papillomavirus (HR-HPV)
11%
Paclitaxel
11%
Intensity-modulated Radiotherapy
10%
Locally Advanced
9%
Tumor
8%
Re-irradiation
8%
Neck Dissection
8%
Locoregional Control
7%
Nasopharyngeal Carcinoma
7%
Hazard Ratio
7%
Continuous Infusion
7%
Local Control
7%
Phase I Study
7%
Distant Metastasis
6%
Progression-free Survival
6%
Proton Therapy
6%
NRG Oncology
6%
Squamous Cell Carcinoma of Head
6%
Intensity-modulated Proton Therapy
6%
Definitive Radiotherapy
6%
Phase II Trial
6%
Clinical Outcomes
6%
Cisplatin
5%
Induction Chemotherapy
5%
Chemoradiation
5%
Locoregionally Advanced
5%
Disease Control
5%
Xerostomia
5%
Chemotherapy
5%
Cetuximab
5%
Confidence Interval
5%
Neck Radiation
5%
Failure Pattern
5%
High Risk
5%
MD Anderson Symptom Inventory (MDASI)
5%
Overall Survival Rate
5%